Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Sets The Stage For A Biosimilar Showdown Over Exclusive Contracts

Executive Summary

Pfizer filed a lawsuit against J&J over its efforts to block sales of Pfizer's biosimilar Inflectra through exclusive contracting for Remicade. The suit claims J&J coerced payers by vowing to withhold all Remicade rebates if any Inflectra is reimbursed. J&J says Pfizer has failed to show the value of Inflectra.

Advertisement

Related Content

Pharma Q3 Results Preview: J&J, Roche Set The Scene
J&J Immunology President On Remicade, Inflectra And The Art Of Contract Negotiations
Shire Vs Allergan Brings Exclusive Contracts Out Of The Shadows (Again)
Too Bold By Half: Allergan’s Latest Moves And Pharma’s Leadership Deficit
Exclusive Remicade Contracts Are Slowing Biosimilar Uptake
Remicade: Biosimilars And Pricing Pressure Wear On J&J's Blockbuster Brand
Pfizer Will Support Inflectra Launch With Dedicated Sales Force

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC099528

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel